It Takes a Village

07/16/2020

The environment around plasma collection, plasma research, and plasma therapies is vast and immense. So here’s a primer of some partners in the critical, life-saving work of plasma:

The American College of Allergy, Asthma, and Immunology (ACAAI) and American Academy of Allergy, Asthma & Immunology (AAAAI) are both physician membership organizations. As such, they provide professional training and a library of resources related to plasma protein therapies and their use.

American Plasma Users Coalition (APLUS) is a membership organization comprised of patient advocacy organizations that represent individuals who are dependent on plasma protein therapies. APLUS advocates for public policy, regulations, directives, guidelines, and recommendations that improve access to therapy and treatment.

The Center for Biologics Evaluation and Research (CBER), a part of the U.S. Food & Drug Administration (FDA), is responsible for the safety of blood and blood components, which includes the plasma collection process. This may include safety inspections of facilities, regulations and protocols, and promoting an adequate supply of blood and blood products. Clinical Immunologic Society (CIS) fosters developments in science and the practice of clinical immunology. Their focus on scientific advancements, medical research, and clinical practice often includes promoting the use of biologic therapies and treatments.

IG Living is a periodical publication focused on immunoglobulin therapies published by FFF Enterprises.  With 30,000 subscribers, this magazine provides information about clinical research, treatments, and immunoglobulin therapy.

The Immunoglobulin National Society (IgNS) is a professional membership organization for healthcare professionals that provides professional education and certification and maintains standards of practice for immunoglobulin (Ig) therapies. They recently launched a plasma donation initiative entitled It’s My Turn.

iPlasma is a blood and plasma technology start-up, founded in 2018. Their website features information on donation centers and hosts a regularly-scheduled podcast as well as a plasma center location tool.

Plasma Protein Therapeutics Association (PPTA) is a global organization representing private plasma protein therapy manufacturers, whose products treat a variety of rare diseases and serious medical conditions. As part of their mission, they advocate for affordable therapies, engage with regulatory agencies, collaborate with patient advocacy organizations, and house an interactive map for individuals looking for donation centers.

News & Updates

Get the latest information on plasma through our news and updates. Featuring: Scientific discoveries, plasma supply, industry-related coverage, policy and legislation, and more!

How plasma saved lives through the ages, from 1918 to WWII to today

11/07/2023

Both convalescent plasma and plasma-based therapies have been around for some time, though many people are still unfamiliar with their history.
Read More

Science-based policies boost plasma donation globally

10/02/2023

Science is driving global advancements in policy and allowing more people around the world to donate plasma while ensuring the safety of donors and the plasma collected.
Read More

How plasma-based therapies treat hemophilia

07/06/2023

Plasma has been used to treat bleeding disorders like hemophilia since the 1950s, and is still one of the most effective treatment options for patients.
Read More

GBS, CIDP, and plasma

05/18/2023

Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are rare neurological disorders and plasma-based therapies are used to treat them.
Read More

FDA proposes risk-based rules for plasma and blood donations

05/17/2023

On January 27, 2023, the U.S. Food and Drug Administration announced a draft proposal for eligibility rules for blood and blood product donation using “gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV.”
Read More

Stiff person syndrome and plasma

04/25/2023

SPS is a rare and progressive neurological disease. It affects one person in a million and Celine Dion is one of those people relying on plasma donation to treat the condition.
Read More
Powered By:
Mojo Creative Digital